You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,736,670


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,736,670
Title:Method of making particles for use in a pharmaceutical composition
Abstract: The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method.
Inventor(s): Staniforth; John Nicholas (Bath, GB), Green; Matthew Michael James (Surrey, GB), Morton; David Alexander Vodden (Bath, GB)
Assignee: Vectura Limited (Chippenham Wiltshire, GB)
Application Number:10/433,072
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,736,670

Introduction

Patents are a crucial component of intellectual property law, providing inventors with exclusive rights to their inventions. The United States Patent 7,736,670, like any other patent, is governed by the Patent Act (35 U.S. Code) and the regulations of the United States Patent and Trademark Office (USPTO). Here, we will delve into the details of this specific patent, exploring its scope, claims, and the broader patent landscape.

Patent Overview

United States Patent 7,736,670 is a utility patent, which is the most common type of patent. Utility patents protect new and useful processes, machines, manufactures, or compositions of matter, or any improvement thereof[1].

Patent Claims

The claims section of a patent is critical as it defines the scope of the invention and what is protected. Here are some key points to consider:

Claim Structure

Patent claims are typically divided into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Scope

The scope of the claims in Patent 7,736,670 would be determined by the language used in the claims themselves. Narrower claims are generally more likely to be granted and less likely to face challenges during the examination process, as they are more specific and less likely to overlap with prior art[3].

Patent Eligibility

Patent eligibility is a critical aspect, especially under Section 101 of the Patent Act. This section requires that the invention be a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. However, there is an implicit exception for abstract ideas, laws of nature, and natural phenomena[2].

Alice Test

The Alice test, a two-step framework established by the Supreme Court, is used to determine if a claim is directed to patent-ineligible subject matter. First, it must be determined if the claim is directed to an abstract idea. If so, the second step involves assessing whether the claim includes additional elements that transform the abstract idea into a patent-eligible invention[2].

Specific Analysis of Patent 7,736,670

Invention Description

To analyze the scope and claims of Patent 7,736,670, one must first understand the invention itself. This involves reviewing the specification and drawings provided in the patent. The invention could be related to any field, such as technology, medical devices, or software, and the claims would need to be evaluated in the context of that field.

Claim Examples

For example, if the patent is related to software or AI, the claims would need to integrate any abstract ideas into practical applications to be considered patent-eligible. This could involve specifying how the invention improves technology or provides a tangible benefit, as illustrated in the 2024 USPTO guidance update on AI patents[4].

Recent Developments and Guidance

2024 USPTO Guidance Update

The recent USPTO guidance update on AI patents provides valuable insights into how patent eligibility is determined for AI-related inventions. This update emphasizes the importance of integrating judicial exceptions into practical applications and highlights the need for meaningful limits on the exception to transform the claim into patent-eligible subject matter[4].

Practical Applications

For a claim to be patent-eligible, it must demonstrate a concrete technological improvement. For instance, if the patent involves an artificial neural network, the claim must show how the neural network is applied in a specific, practical way that improves technology, such as enhancing the accuracy of voice commands in a hands-free environment[4].

Patent Landscape and Trends

Patent Scope Metrics

Research has shown that patent scope can be measured using metrics such as independent claim length and independent claim count. These metrics have explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Quality and Validity

The debate over patent quality and validity is ongoing. There is a concern that broader patents with decreased clarity and questionable validity can diminish innovation incentives due to increased licensing and litigation costs. Therefore, ensuring that patents have clear and narrow claims is crucial for maintaining the integrity of the patent system[3].

Litigation and Enforcement

Patent Infringement

Patent infringement cases, such as AI Visualize, Inc. v. Nuance Communications, Inc., highlight the importance of ensuring that patent claims are directed to patent-eligible subject matter. The courts apply the Alice test to determine if the claims are valid, and the outcome can significantly impact the enforceability of the patent[2].

Small Claims Patent Court

There is an ongoing discussion about the feasibility of a small claims patent court, which could potentially simplify and reduce the costs associated with patent litigation. This initiative involves studying the legal, policy, and practical considerations of establishing such a court[5].

Key Takeaways

  • Patent Claims: The claims section of a patent defines the scope of the invention and must be carefully crafted to ensure patent eligibility.
  • Patent Eligibility: The Alice test is crucial in determining if a claim is directed to patent-ineligible subject matter, and integrating abstract ideas into practical applications is essential.
  • Recent Guidance: The 2024 USPTO guidance update provides clear examples and criteria for evaluating the patent eligibility of AI-related inventions.
  • Patent Scope: Metrics such as independent claim length and count can help measure patent scope and ensure that patents are clear and valid.
  • Litigation: Ensuring that patent claims are valid and directed to patent-eligible subject matter is critical for successful enforcement.

FAQs

  1. What is the primary purpose of the claims section in a patent?

    • The primary purpose of the claims section is to define the scope of the invention and specify what is protected under the patent.
  2. How does the Alice test impact patent eligibility?

    • The Alice test is a two-step framework used to determine if a claim is directed to patent-ineligible subject matter. It assesses whether the claim is an abstract idea and if additional elements transform it into a patent-eligible invention.
  3. What is the significance of the 2024 USPTO guidance update on AI patents?

    • The update clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and criteria to help practitioners draft claims that are more likely to avoid section 101 rejections.
  4. How can the scope of a patent be measured?

    • The scope of a patent can be measured using metrics such as independent claim length and independent claim count, which have explanatory power for various correlates of patent scope.
  5. Why is the discussion about a small claims patent court important?

    • The discussion is important because it aims to simplify and reduce the costs associated with patent litigation, making it more accessible for smaller entities to enforce their patent rights.

Sources

  1. BitLaw - Patent Law in the United States
  2. CAFC - AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC.
  3. SSRN - Patent Claims and Patent Scope
  4. Mintz - Understanding the 2024 USPTO Guidance Update on AI Patent
  5. ACUS - U.S. Patent Small Claims Court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,736,670

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,736,670

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0029261.5Nov 30, 2000
United Kingdom0030946.8Dec 19, 2000
PCT/GB01/01606Apr 9, 2001
United Kingdom0124010.0Oct 5, 2001
PCT Information
PCT FiledNovember 30, 2001PCT Application Number:PCT/GB01/05315
PCT Publication Date:June 06, 2002PCT Publication Number: WO02/43701

International Family Members for US Patent 7,736,670

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1267866 ⤷  Subscribe C300583 Netherlands ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe CA 2013 00015 Denmark ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe 92166 Luxembourg ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe C300651 Netherlands ⤷  Subscribe
European Patent Office 1267866 ⤷  Subscribe CA 2014 00020 Denmark ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.